Alaunos Therapeutics Inc. logo

Alaunos Therapeutics Inc.

TCRT | NASDAQ
Chart Builder DCF Calculator
$1.26
+$0.06 (+5.00%)
At close: Sep 21, 2026, 4:00 PM ET
$1.26
$0 (0.00%)
After-hours: Sep 21, 2026, 7:38 PM ET

Market Data

Market Cap
$2.93M
Enterprise Value
$2.95M
Beta
-0.97
Average Volume
14.13K
Shares Outstanding (Diluted)
2.43M
Shares Change YoY
45.06%
Institutional Ownership
6.46%
Exchange
NASDAQ
ISIN
US98973P3091

Price Performance

Price Change 1M
-28.8%
Price Change 3M
-41.4%
Price Change 6M
-58.1%
Price Change YTD
-61.6%
Price Change 1Y
-49.2%
Price Change 3Y
-93.4%
Price Change 5Y
-99.6%
1M CAGR (ann.)
-39.7%
1Y CAGR (ann.)
-50.0%
5Y CAGR (ann.)
-66.5%
All-Time CAGR
-27.8%

Valuation

PE Ratio
-0.65
Forward PE
N/A
PEG Ratio
-0.03
Forward PEG
0.04
PS Ratio
1,025.70
Forward PS
0.00
PB Ratio
4.72
P/FCF Ratio
-1.09
P/Adj. FCF Ratio
-0.99
P/OCF Ratio
-1.12
EV/Sales
984.37
EV/EBIT
-0.97
EV/EBITDA
-0.74
EV/FCF
-1.05
Earnings Yield
-154.8%
FCF Yield
-91.8%
Adj. FCF Yield
-100.7%

Financial Health

Net Cash
$124K
Total Debt
$0
Cash & Short-Term Investments
$124K
Total Assets
$1.52M
Current Ratio
0.77
Quick Ratio
0.77
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
0.00
Altman Z-Score
-860.46
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
-28133.3%
Operating Profit Margin
-135266.7%
EBITDA Margin
-132866.7%
Net Profit Margin
-133666.7%
FCF Margin
-94166.6%
Adj. FCF Margin
-103333.3%
SBC / Revenue
9166.7%
SBC Impact (per share)
-9.7%

Returns

Return on Assets
-264.5%
Return on Equity
-232.6%
Return on Invested Capital
-622.4%
Return on Capital Employed
-622.4%
Return on Tangible Assets
-264.5%

Historical Growth (CAGR)

Revenue CAGR 3Y
-89.9%
Revenue CAGR 5Y
-55.6%
Revenue CAGR 10Y
-54.2%
EPS CAGR 3Y
91.7%
EPS CAGR 5Y
59.8%
EPS CAGR 10Y
19.8%
FCF CAGR 3Y
94.7%
FCF CAGR 5Y
55.3%
FCF CAGR 10Y
17.2%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 16, 2026
EPS Estimate (next Q)
-$15.75
EPS Growth Est (next Q)
2763.6%
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Cash Flow

Operating Cash Flow
$-2.73M
Free Cash Flow
$-2.82M
Adj. Free Cash Flow
$-3.1M
FCF Per Share
-$1.16
OCF Per Share
-$1.12
OCF/S Ratio
-90900.0%

Income Statement

Revenue
$3K
Gross Profit
$-835K
Operating Income
$-4.06M
EBITDA
$-4M
Net Income
$-4.01M
EPS (Diluted)
-$1.95
Revenue / Employee
$3K
Profit / Employee
$-4.01M
Employees
1

© 2026 bestshares.com. All rights reserved.